SAN FRANCISCO, April 25, 2018 -- Hagens Berman Sobol Shapiro LLP reminds investors in Henry Schein, Inc. (NASDAQ:HSIC) of the May 7, 2018 Lead Plaintiff deadline in the securities class action pending in the United States District Court for the Eastern District of New York. If you purchased or otherwise acquired Henry Schein securities between March 7, 2013 and February 12, 2018 and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more information visit:
https://www.hbsslaw.com/cases/HSIC
or contact Reed Kathrein, who is leading the firm’s investigation, by calling 510-725-3000 or emailing
On February 12, 2018, the United States Federal Trade Commission (“FTC”) announced it sued Henry Schein and two other dental supply companies.
The FTC charges the Company: (a) illegally restrained price competition for dental products in the United States; (b) distorted prices and undermined the ability of independent dentists to obtain lower prices and discounts for dental products; (c) deprived independent dentists of the benefits of vigorous price and service competition among full-service, national dental distributors; (d) unreasonably reduced output of dental products to dental buying groups; and (e) eliminated or reduced the competitive bidding process for sales to these buying groups.
This news drove the price of Henry Schein shares down $4.79, or about 6.6%, to close at $67.39 on February 13, 2018.
“Henry Schein investors have suffered enormous losses,” said Hagens Berman partner Reed Kathrein. “We’re focused on Defendants’ statements to investors about the Company’s revenues and purported industry competition.”
Whistleblowers: Persons with non-public information regarding Henry Schein should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is a national investor-rights law firm headquartered in Seattle, Washington with 70+ attorneys in 11 offices across the country. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the firm and its successes can be found at www.hbsslaw.com. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact:
Reed Kathrein, 510-725-3000


Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Japan Earthquake Disrupts Auto and Chip Supply Chains
World game at war: why some European nations have threatened a World Cup boycott
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
Capital One Says AML Review Led to Closure of Trump Organization Accounts
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel 



